Literature DB >> 24608550

Redesigning care to meet national recommendation of four or more yearly clinic visits in patients with cystic fibrosis.

A Berlinski1, M J Chambers, L Willis, K Homa, G Com.   

Abstract

Cystic fibrosis (CF) is a chronic disease requiring patients to have frequent specialty healthcare visits to delay progression of lung disease, prevent and treat failure to thrive and initiate early interventions to prevent acute illness and complications. The CF Foundation recommends that patients have visits with the CF care team at least every 3 months. During participation in the CF Foundation Learning and Leadership Collaborative IV, the CF team at Arkansas Children's Hospital initiated quality improvement work with the aim to increase the percentage of patients attending clinic four or more times a year from 35% in 2004 and 56% in 2005 (CF Foundation Registry data) to 90% or greater. We redesigned our scheduling system, rescheduled missed patient appointments in a timely fashion and created a process to monitor attendance. This quality improvement work led to a sustained increase in the percentage of patients attending clinic visits four or more times a year reaching our goal of 90% in 2012. Improvements were also noted in the number of patients with body mass index/weight-for-length centile of 25 or greater, which could be related to more frequent clinic attendance.

Entities:  

Keywords:  Clinical Practice Guidelines; Continuous Quality Improvement; Healthcare Quality Improvement; Paediatrics

Mesh:

Year:  2014        PMID: 24608550     DOI: 10.1136/bmjqs-2013-002345

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  5 in total

1.  Trans-Atlantic collaboration: applying lessons learned from the US CF Foundation quality improvement initiative.

Authors:  Kathryn A Sabadosa; Marjorie M Godfrey; Bruce C Marshall
Journal:  Orphanet J Rare Dis       Date:  2018-02-08       Impact factor: 4.123

2.  Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.

Authors:  Alex H Gifford; Thida Ong; Christopher Dowd; Aricca D Van Citters; Peter Scalia; Kathryn A Sabadosa; Gregory S Sawicki
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

3.  Stay in treatment: Predicting dropout from pediatric weight management study protocol.

Authors:  Diane C Berry; Erinn T Rhodes; Sarah Hampl; Caroline Blackwell Young; Gail Cohen; Ihuoma Eneli; Amy Fleischman; Edward Ip; Brooke Sweeney; Timothy T Houle; Joseph Skelton
Journal:  Contemp Clin Trials Commun       Date:  2021-06-09

4.  Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre.

Authors:  James M Roberts; Pearce G Wilcox; Bradley S Quon
Journal:  Can Respir J       Date:  2016-02-29       Impact factor: 2.409

5.  Explanation and elaboration of the SQUIRE (Standards for Quality Improvement Reporting Excellence) Guidelines, V.2.0: examples of SQUIRE elements in the healthcare improvement literature.

Authors:  Daisy Goodman; Greg Ogrinc; Louise Davies; G Ross Baker; Jane Barnsteiner; Tina C Foster; Kari Gali; Joanne Hilden; Leora Horwitz; Heather C Kaplan; Jerome Leis; John C Matulis; Susan Michie; Rebecca Miltner; Julia Neily; William A Nelson; Matthew Niedner; Brant Oliver; Lori Rutman; Richard Thomson; Johan Thor
Journal:  BMJ Qual Saf       Date:  2016-04-13       Impact factor: 7.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.